Investigational clinical trials are at the heart of innovation in brain tumor treatment.
At the Gerald J. Glasser Brain Tumor Center, we have a robust clinical trial research infrastructure in place. As a member of the National Cancer Institute (NCI) Cooperative Group System – and in partnership with several biotech/pharmaceutical companies and the Translational Genomics Research Institute, we offer patients access to groundbreaking, evolving therapies.
Currently, we are developing novel treatments for:
- Low-grade gliomas
- Other high-grade primary brain tumors
- Metastatic brain tumors
- Tumors that cause malignant cells to spread to the fluid surrounding the brain and spinal cord.
To treat these challenging tumors, we are focusing on immunotherapies, CAR-T strategies, oncolytic tumor viruses and other targeted therapies.
If you’re interested in learning more about specific clinical trials that are underway and enrollment, please contact 908-522-5768.